O'Higgins N - Search Results

1

Metalloproteinases: role in breast carcinogenesis, invasion and metastasis.

Duffy MJ, Maguire TM, Hill A, McDermott E, O'Higgins N. Duffy MJ, et al. Breast Cancer Res. 2000;2(4):252-7. doi: 10.1186/bcr65. Epub 2000 Jun 7. Breast Cancer Res. 2000. PMID: 11250717 Free PMC article. Review.

2

CA 15-3 in patients with locoregional and metastatic breast carcinoma.

Geraghty JG, Coveney EC, Sherry F, O'Higgins NJ, Duffy MJ. Geraghty JG, et al. Cancer. 1992 Dec 15;70(12):2831-4. doi: 10.1002/1097-0142(19921215)70:12<2831::aid-cncr2820701218>3.0.co;2-8. Cancer. 1992. PMID: 1451063

3

A positive role for PEA3 in HER2-mediated breast tumour progression.

Myers E, Hill AD, Kelly G, McDermott EW, O'Higgins NJ, Young LS. Myers E, et al. Br J Cancer. 2006 Nov 20;95(10):1404-9. doi: 10.1038/sj.bjc.6603427. Epub 2006 Oct 24. Br J Cancer. 2006. PMID: 17060941 Free PMC article.

4

Assay of E-cadherin by ELISA in human breast cancers.

Maguire TM, Shering SG, McDermott EW, O'Higgins N, Fennelly JJ, Crown J, Duffy MJ. Maguire TM, et al. Eur J Cancer. 1997 Mar;33(3):404-8. doi: 10.1016/s0959-8049(97)89013-2. Eur J Cancer. 1997. PMID: 9155524

5

Plasminogen activator inhibitor type 2 in breast cancer.

Duggan C, Kennedy S, Kramer MD, Barnes C, Elvin P, McDermott E, O'Higgins N, Duffy MJ. Duggan C, et al. Br J Cancer. 1997;76(5):622-7. doi: 10.1038/bjc.1997.435. Br J Cancer. 1997. PMID: 9303361 Free PMC article.

6

High levels of tissue inhibitor of metalloproteinase-1 predict poor outcome in patients with breast cancer.

McCarthy K, Maguire T, McGreal G, McDermott E, O'Higgins N, Duffy MJ. McCarthy K, et al. Int J Cancer. 1999 Feb 19;84(1):44-8. doi: 10.1002/(sici)1097-0215(19990219)84:1<44::aid-ijc9>3.0.co;2-p. Int J Cancer. 1999. PMID: 9988231

7

Urokinase plasminogen activator: a prognostic marker in multiple types of cancer.

Duffy MJ, Maguire TM, McDermott EW, O'Higgins N. Duffy MJ, et al. J Surg Oncol. 1999 Jun;71(2):130-5. doi: 10.1002/(sici)1096-9098(199906)71:2<130::aid-jso14>3.0.co;2-9. J Surg Oncol. 1999. PMID: 10389872 Review.

8

CA 15-3: a prognostic marker in breast cancer.

Duffy MJ, Shering S, Sherry F, McDermott E, O'Higgins N. Duffy MJ, et al. Int J Biol Markers. 2000 Oct-Dec;15(4):330-3. doi: 10.1177/172460080001500410. Int J Biol Markers. 2000. PMID: 11192829 Free article.

9

Overexpression of the Ets-1 transcription factor in human breast cancer.

Buggy Y, Maguire TM, McGreal G, McDermott E, Hill AD, O'Higgins N, Duffy MJ. Buggy Y, et al. Br J Cancer. 2004 Oct 4;91(7):1308-15. doi: 10.1038/sj.bjc.6602128. Br J Cancer. 2004. PMID: 15365563 Free PMC article.

10

Urokinase-plasminogen activator, a new and independent prognostic marker in breast cancer.

Duffy MJ, Reilly D, O'Sullivan C, O'Higgins N, Fennelly JJ, Andreasen P. Duffy MJ, et al. Cancer Res. 1990 Nov 1;50(21):6827-9. Cancer Res. 1990. PMID: 2119883

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

201 results

Search Page

Filters